ATE525389T1 - Antibakterielle und antivirale peptide aus actinomadura namibiensis - Google Patents

Antibakterielle und antivirale peptide aus actinomadura namibiensis

Info

Publication number
ATE525389T1
ATE525389T1 AT07818379T AT07818379T ATE525389T1 AT E525389 T1 ATE525389 T1 AT E525389T1 AT 07818379 T AT07818379 T AT 07818379T AT 07818379 T AT07818379 T AT 07818379T AT E525389 T1 ATE525389 T1 AT E525389T1
Authority
AT
Austria
Prior art keywords
antibacterial
antiviral peptides
actinomadura namibiensis
namibiensis
actinomadura
Prior art date
Application number
AT07818379T
Other languages
English (en)
Inventor
Gerhard Seibert
Laszlo Vertesy
Joachim Wink
Irvin Winkler
Roderich Suessmuth
George Sheldrick
Kathrin Meindl
Mark Broenstrup
Holger Hoffmann
Hans Guehring
Luigi Toti
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37836831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE525389(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE525389T1 publication Critical patent/ATE525389T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07818379T 2006-10-06 2007-09-25 Antibakterielle und antivirale peptide aus actinomadura namibiensis ATE525389T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06020980A EP1908774A1 (de) 2006-10-06 2006-10-06 Antibakterielle und antivirale Peptide aus Actinomadura namibiensis
PCT/EP2007/008294 WO2008040469A1 (en) 2006-10-06 2007-09-25 Antibacterial and antiviral peptides from actinomadura namibiensis

Publications (1)

Publication Number Publication Date
ATE525389T1 true ATE525389T1 (de) 2011-10-15

Family

ID=37836831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07818379T ATE525389T1 (de) 2006-10-06 2007-09-25 Antibakterielle und antivirale peptide aus actinomadura namibiensis

Country Status (21)

Country Link
US (1) US8476222B2 (de)
EP (2) EP1908774A1 (de)
JP (1) JP5204779B2 (de)
KR (1) KR101504492B1 (de)
CN (1) CN101522705B (de)
AR (1) AR063140A1 (de)
AT (1) ATE525389T1 (de)
AU (1) AU2007304536B2 (de)
BR (1) BRPI0719978A2 (de)
CA (1) CA2665269C (de)
CL (1) CL2007002889A1 (de)
IL (1) IL197971A (de)
MA (1) MA31133B1 (de)
MX (1) MX2009002962A (de)
MY (1) MY147920A (de)
NO (1) NO20091788L (de)
NZ (1) NZ576039A (de)
RU (1) RU2451028C2 (de)
UY (1) UY30629A1 (de)
WO (1) WO2008040469A1 (de)
ZA (1) ZA200901321B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0910985A2 (pt) * 2008-04-02 2019-09-24 Sanofi Aventis peptídeos de actinomadura namibiensis altamente ligados em ponte
EP2607374A1 (de) 2011-12-21 2013-06-26 Sanofi Verfahren zur rekombinanten Herstellung von Labyrinthopeptinen und funktionalen Derivaten davon
CN103421100B (zh) * 2012-05-22 2015-11-18 中国科学院动物研究所 一种抗菌肽及其制备方法和应用
US10487124B2 (en) 2012-07-12 2019-11-26 Naicons S.R.L. Lantipeptide
WO2017085257A1 (en) 2015-11-18 2017-05-26 Helmholtz-Zentrum für Infektionsforschung GmbH Labyrinthopeptins as anti-viral agents
CN106188253B (zh) * 2016-08-26 2020-08-18 上海交通大学 抗菌肽Lexapeptide及其制备方法和用途
CN110400607B (zh) * 2019-07-17 2020-06-02 杭州费尔斯通科技有限公司 一种分子式库的扩展方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19745583A1 (de) * 1997-10-15 1999-04-22 Hoechst Marion Roussel De Gmbh Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben
BRPI0910985A2 (pt) * 2008-04-02 2019-09-24 Sanofi Aventis peptídeos de actinomadura namibiensis altamente ligados em ponte

Also Published As

Publication number Publication date
US8476222B2 (en) 2013-07-02
CA2665269A1 (en) 2009-04-02
CN101522705B (zh) 2013-10-02
EP2076529A1 (de) 2009-07-08
BRPI0719978A2 (pt) 2014-08-12
MY147920A (en) 2013-02-15
NO20091788L (no) 2009-06-24
KR20090075679A (ko) 2009-07-08
KR101504492B1 (ko) 2015-03-23
JP5204779B2 (ja) 2013-06-05
US20090298904A1 (en) 2009-12-03
JP2010505777A (ja) 2010-02-25
WO2008040469A1 (en) 2008-04-10
IL197971A (en) 2015-08-31
IL197971A0 (en) 2011-08-01
AR063140A1 (es) 2008-12-30
CL2007002889A1 (es) 2008-04-18
ZA200901321B (en) 2009-12-30
AU2007304536B2 (en) 2012-08-23
HK1135708A1 (en) 2010-06-11
MA31133B1 (fr) 2010-02-01
CN101522705A (zh) 2009-09-02
EP2076529B1 (de) 2011-09-21
AU2007304536A1 (en) 2008-04-10
EP1908774A1 (de) 2008-04-09
RU2009117220A (ru) 2010-11-20
MX2009002962A (es) 2009-04-01
UY30629A1 (es) 2008-05-31
NZ576039A (en) 2011-07-29
CA2665269C (en) 2015-07-14
RU2451028C2 (ru) 2012-05-20

Similar Documents

Publication Publication Date Title
CY2022032I1 (el) Συνθετικα πεπτιδικα αμιδια
EP2118122A4 (de) Neuartige antimikrobielle peptide
EP2061488A4 (de) Selektiv gezielte antimikrobielle peptide und ihre anwendung
DK3120862T3 (da) Antimikrobielt peptid og sammensætninger deraf
EP2093287A4 (de) Igg bindendes peptid
IL199041A (en) We nanoparticle peptides and their uses
ATE534660T1 (de) Peptidsequenzen und zusammensetzungen
GB0712670D0 (en) Isolated peptides and uses thereof
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
EP2017283A4 (de) Peptide
EP2010561A4 (de) Antimikrobielle peptide
EP1976864A4 (de) Neues peptid und seine verwendung
IL185308A0 (en) Replikin peptides and uses thereof
ATE525389T1 (de) Antibakterielle und antivirale peptide aus actinomadura namibiensis
GB0508863D0 (en) Peptide
EP2513137A4 (de) Aus saposin-a gewonnene peptide und verwendungen davon
IL195525A0 (en) Replikin peptides and uses thereof
DE602006003063D1 (de) Tripeptid- und tetrapeptidsulfone
ATE547425T1 (de) Optimiertes dengue-virus-eintrittshemmendes peptid (dn81)
DE602005012757D1 (de) Antibakterielles Peptid
ATE541856T1 (de) Stark verbrückte peptide aus der actinomadura namibiensis
EP2017285A4 (de) Antimikrobielle lineare peptide
DK2021364T3 (da) Forbedrede antimikrobielle peptider
GB0604187D0 (en) Peptide and uses thereof
EP1968623A4 (de) Bakteriocin-vermittler-peptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties